---
$id: https://graph.org.ai/products/commodity/51313407
$type: Product
source: UNSPSC
code: "51313407"
title: "Dexbrompheniramine"
class: "51313400"
classTitle: "Antihistamine or H1 blocker pyridines"
family: "51310000"
familyTitle: "Antihistamines or H1 blockers"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dexbrompheniramine

**UNSPSC Code**: 51313407
**Class**: [Antihistamine or H1 blocker pyridines](Antihistamine or H1 blocker pyridines.mdx)
**Family**: [Antihistamines or H1 blockers](../Antihistamines or H1 blockers.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H19BrN2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 75T64B71RP, chemically known as 3-(4-bromophenyl)-n,n-dimethyl-3-pyridin-2-yl-propan-1-amine but generally known as dexbrompheniramine, which bears US NIH Compound Identifier 16960. European Medicines Agency schedules Dexbrompheniramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07021MIG. World Health Organization schedules dexbrompheniramine in its Anatomical Therapeutic Chemical (ATC) Classification. DEXBROMPHENIRAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dexbrompheniramine under HS 29333999 and SITC 51574. As of Q4 2014, DEXBROMPHENIRAMINE remains the US FDA Preferred Term for this commodity. Dexbrompheniramine bears US NLM identifiers UMLS ID C0057605 and NCI Concept Code C61705. SMILES: BRC1CCC(C(CCN(C)C)C2NCCCC2)CC1.

